PCN214 - IBRITUMOMAB TIUXETAN RADIOLABELLED WITH YTTRIUM CHLORIDE- 4 YEARS OF USE IN THE 37 PUBLIC HOSPITALS OF PARIS AND IN FRANCE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.296
https://www.valueinhealthjournal.com/article/S1098-3015(18)33596-4/fulltext
Title :
PCN214 - IBRITUMOMAB TIUXETAN RADIOLABELLED WITH YTTRIUM CHLORIDE- 4 YEARS OF USE IN THE 37 PUBLIC HOSPITALS OF PARIS AND IN FRANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33596-4&doi=10.1016/j.jval.2018.09.296
First page :
Section Title :
Open access? :
No
Section Order :
2202